(Q38867574)

English

Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients

scientific article published on September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Human T-lymphotropic virus 1

0 references

1 reference

based on heuristic

inferred from title

spastic paraparesis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Carolina Alberti

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Luis Cartier

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

María A Valenzuela

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Javier Puente

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yuetsu Tanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Eugenio Ramirez

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

83

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1641-1649

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

CyProQuant-PCR: A real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

A double-blind controlled trial of high dose methyl prednisolone in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Immunohistochemistry of degenerative changes in the central nervous system in spastic paraparesis associated to human T lymphotropic virus type I (HTLV-I)

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

The pathogenesis of tropical spastic paraparesis/human T-cell leukemia type I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Corticosteroid therapy in TSP/HAM patients: the results from a 10 years open cohort.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Interferon-alpha significantly reduces cerebrospinal fluid CD4 cell subsets in HAM/TSP.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate on blood glucose levels in controlled diabetic patients with symptomatic osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Ultrastructural pathology of a Chilean case of tropical spastic paraparesis/human T-cell lymphotropic type I-associated myelopathy (TSP/HAM).

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

HTLV-I associated myelopathy, a new clinical entity.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Is FOXP3 a bona fide marker for human regulatory T cells?

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on Foxp3 and IL-10 expression

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Human T cell leukemia virus type I (HTLV-I) and human diseases

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Human T-lymphotropic virus 1: recent knowledge about an ancient infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22131

21 January 2018

Identifiers

10.1002/JMV.22131

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38867574&oldid=1792663425"